Advertisement

A Rare Case of a Large Spinal Meningioma with Mediastinal Extension and Malignant Behavior Classified Histologically as Benign

  • S. Dahdal
  • R. H. Andres
  • E. Hewer
  • J. C. Reubi
  • B. Klaeser
  • A. Raabe
  • N. Cihoric
  • R. Schmid
  • K. Tänzler
  • T. Krause
  • D. M. Aebersold
  • M. Schmuecking
Conference paper
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 194)

Abstract

Aim: To report a rare case of a spinal WHO grade I meningioma extending through intervertebral foramina C7 to D4 with an extensive mediastinal mass and infiltration of the vertebrae, and to discuss the malignant behavior of a tumor classified as benign. Methods (Clinical Presentation, Histology, and Imaging): A 54-year-old man suffered from increasing lower back pain with gait difficulties, weakness and numbness of the lower extremities, as well as urge incontinence. CT scan of the thorax and MRI scan of the spine revealed a large prevertebral tumor, which extended to the spinal canal and caused compression of the spinal cord at the levels of C7 to D4 leading to myelopathy with hyperintense signal alteration on T2-weighted MRI images. The signal constellation (T1 with and without contrast, T2, TIR) was highly suspicious for infiltration of vertebrae C7 to D5. Somatostatin receptor SPECT/CT with 111In-DTPA-d-Phe-1-octreotide detected a somatostatin receptor-positive mediastinal tumor with infiltration of multiple vertebrae, dura, and intervertebral foramina C7–D4, partially with Krenning score >2. Percutaneous biopsies of the mediastinal mass led to histopathological findings of WHO grade I meningioma of meningothelial subtype. Results (Therapy): C7 to D4 laminoplasty was performed, and the intraspinal, extradural part of the tumor was microsurgically removed. Postoperative stereotactic radiation therapy was done using the volumetric modulated arc therapy (VMAT) technique (RapidArc). No PRRNT with 90Y-DOTA-TOC was done. Conclusions: Due to the rare incidence and complex presentation of this disease not amenable to complete surgical resection, an individualized treatment approach should be worked out interdisciplinarily. The treatment approach should be based not only on histology but also on clinical and imaging findings. Close clinical and radiological follow-up may be mandatory even for benign tumors.

Keywords

Peptide Receptor Radionuclide Therapy Liver Uptake Benign Meningioma Spinal Meningioma Intervertebral Foramina 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Barbanera A, Nina P, Serchi E, Ascanio F (2007) Aggressive recurrence of intra-extradural cervico-thoracic meningothelial meningioma. Acta Neurochir (Wien) 149:83–86CrossRefGoogle Scholar
  2. Baum RP, Söldner J, Schmücking M, Niesen A (2004a) Peptidrezeptorvermittelte Radiotherapie (PRRT) neuroendokriner Tumoren. Klinische Indikationen und Erfahrung mit 90Yttrium-markierten Somatostatinanaloga. Onkologe 10:1098–1110Google Scholar
  3. Baum RP, Soeldner J, Schmuecking M (2004b) Clinical results of peptide receptor radionuclide therapy (PRRT) with yttrium-90-DOTA-TYR3-OCTREOTATE (Y-90 DOTA-TATE) in patients with neuroendocrine tumors. J Nucl Med 45:90PGoogle Scholar
  4. Buchfelder M Nomikos P, Paulus W, Rupprecht H (2001) Spinal-thoracic dumbbell meningioma: a case report. Spine (Phila Pa 1976) 26:1500–1504Google Scholar
  5. Central Brain Tumor Registry of the United States (CBTRUS): Statistical report: Primary brain tumors in the United States, 2000–2004Google Scholar
  6. Engelhard HH et al (2010) Clinical presentation, histology, and treatment in 430 patients with primary tumors of the spinal cord, spinal meninges, or cauda equina. J Neurosurg Spine 13(1):67–77PubMedCrossRefGoogle Scholar
  7. Forrer F et al (2006) Targeted radionuclide therapy with 90Y-DOTATOC in patients with neuroendocrine tumors. Anticancer Res 26(1B):703–707PubMedGoogle Scholar
  8. Gambardella G, Gervasio O, Zaccone C (2003) Approaches and surgical results in the treatment of ventral thoracic meningiomas. Review of our experience with a postero-lateral combined transpedicular-transarticular approach. Acta Neurochir (Wien) 145:385–392Google Scholar
  9. Gerszten PC, Burton SA, Ozhasoglu C, McCue KJ, Quinn AE (2008) Radiosurgery for benign intradural spinal tumors. Neurosurgery 62:887–895PubMedCrossRefGoogle Scholar
  10. Goldsmith BJ, Wara WM, Wilson CB, Larson DA (1994) Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80:195–201PubMedCrossRefGoogle Scholar
  11. Guevara P, Escobar-Arriaga E, Saavedra-Perez D, Martinez-Rumavor A, Flores-Estrada D, Rembao D, Calderon A, Sotelo J, Arrieta O (2010) Angiogenesis and expression of estrogen and progesterone receptors as predictive factors for recurrence of meningioma. J Neurooncol 98:379–384PubMedCrossRefGoogle Scholar
  12. Imhof Anna, Brunner Philippe, Marincek Nicolas, Briel Matthias, Schindler Christian, Rasch Helmut, Maecke HelmutR, Rochlitz Christoph, Mueller-Brand Jan, Walter MartinA (2011) Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue 90Y-DOTA-TOC in metastasized neuroendocrine cancers. J Clin Oncol 29:2416–2423PubMedCrossRefGoogle Scholar
  13. Incarbone M, Ceresoli GL, Di Tommaso L, Cappuzzo F, Inzirillo F, Infante M, Alloisio M (2008) Primary pulmonary meningioma: report of a case and review of the literature. Lung Cancer 62:401–407PubMedCrossRefGoogle Scholar
  14. Jenkinson MD, Simpson C, Nicholas RS, Miles J, Findlay GF, Pigott TJ (2006) Outcome predictors and complications in the management of intradural spinal tumours. Eur Spine J 15:203–210PubMedCrossRefGoogle Scholar
  15. Kaemmerer D, Peter L, Lupp A, Schulz S, Sänger J, Prasad V, Kulkarni H, Haugvik SP, Hommann M, Baum RP (2011) Molecular imaging with 68Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 38:1659–1668PubMedCrossRefGoogle Scholar
  16. Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, van Hagen M, Postema PT, de Jong M, Reubi JC (1993) Somatostatin receptor scintigraphy with (111In-DTPA-D-Phe1)- and (123I-Tyr3)-octreotide: The Rotterdam experience with more than 1,000 patients. Eur J Nucl Med 20:716–731PubMedCrossRefGoogle Scholar
  17. Kwekkeboom D, Krenning EP, de Jong M (2000) Peptide receptor imaging and therapy. J Nucl Med 41:1704–1713PubMedGoogle Scholar
  18. Lee Y, Liu J, Patel S, Cloughesy T, Lai A, Farooqi H, Seligson D, Dong J, Liau L, Becker D, Mischel P, Shams S, Nelson S (2010) Genomic landscape of meningiomas. Brain Pathol 20:751–762PubMedCrossRefGoogle Scholar
  19. Levy W, Bay J, Dohn D (1982) Spinal cord meningioma. J Neurosurg 57:804–812PubMedCrossRefGoogle Scholar
  20. Mawrin C, Perry A (2010) Pathological classification and molecular genetics of meningiomas. J Neurooncol 99:379–391PubMedCrossRefGoogle Scholar
  21. Menda Y, O’Dorisio M, Kao S, Khanna G, Michael S, Connolly M, Babich J, O’Dorisio T, Bushnell D, Madsen M (2010) Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptors. J Nucl Med 51:1524–1531PubMedCrossRefGoogle Scholar
  22. Mimoto H, Tomita R, Nakahara K, Tanaka H, Hada J, Noguchi K (1991) A case of dumbbell-shaped type extradural spinal meningioma. Kyobu Geka 44:961–964PubMedGoogle Scholar
  23. Nakasu S, Fukami T, Jito J, Nozaki K (2009) Recurrence and regrowth of benign meningiomas. Brain Tumor Pathol 26:69–72PubMedCrossRefGoogle Scholar
  24. Palimento D, Picchio M (2006) Meningioma of the mediastinum causing spontaneous hemothorax. Ann Thorac Surg 81:1903–1904PubMedCrossRefGoogle Scholar
  25. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC (1999) “Malignancy” in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046–2056PubMedGoogle Scholar
  26. Prasad V, Fetscher S, Baum RP (2007) Changing role of somatostatin receptor targeted drugs in NET: Nuclear Medicine’s view. J Pharm Pharm Sci 10:321s–337sPubMedGoogle Scholar
  27. Reubi JC (2004) Somatostatin and other peptide receptors as tools for tumor diagnosis and treatment. Neuroendocrinology 80(Suppl 1):51–56PubMedCrossRefGoogle Scholar
  28. Reubi JC, Schär JC, Waser B, Wenger S, Heppeler A, Schmitt JS, Mäcke HR (2000) Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 27:273–282PubMedCrossRefGoogle Scholar
  29. Rufini V, Calcagni ML, Baum RP (2006) Imaging of neuroendocrine tumors. In: Semin in Nucl Med 36:228–247Google Scholar
  30. Solero CL, Fornari M, Giombini S, Lasio G, Oliveri G, Cimio C, Pluchino F (1989) Spinal meningiomas: review of 174 operated cases. Neurosurgery 125:153–160Google Scholar
  31. Sughrue ME et al (2010) The relevance of simpson grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. J Neurosurg 113:1029–1035PubMedCrossRefGoogle Scholar
  32. Yoon SH, Chung CK, Jahng TA (2007) Surgical outcome of spinal canal meningiomas. J Korean Neurosurg Soc 42:300–304PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • S. Dahdal
    • 1
  • R. H. Andres
    • 2
  • E. Hewer
    • 3
  • J. C. Reubi
    • 3
  • B. Klaeser
    • 4
  • A. Raabe
    • 2
  • N. Cihoric
    • 6
  • R. Schmid
    • 5
  • K. Tänzler
    • 1
  • T. Krause
    • 4
  • D. M. Aebersold
    • 6
  • M. Schmuecking
    • 6
  1. 1.Department of Internal Medicine, InselspitalBern University Hospital, and University of BernBernSwitzerland
  2. 2.Department of Neurosurgery, InselspitalBern University Hospital and University of BernBernSwitzerland
  3. 3.Department of Pathology, InselspitalBern University Hospital and University of BernBernSwitzerland
  4. 4.Department of Nuclear Medicine, InselspitalBern University Hospital, and University of BernBernSwitzerland
  5. 5.Department of Thoracic Surgery, InselspitalBern University Hospital, and University of BernBernSwitzerland
  6. 6.Department of Radiation Oncology, InselspitalBern University Hospital, and University of BernBernSwitzerland

Personalised recommendations